Welcome to our dedicated page for Revvity SEC filings (Ticker: RVTY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Revvity, Inc. (NYSE: RVTY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. Revvity, a Massachusetts-incorporated health science and diagnostics company and member of the S&P 500 index, uses these filings to report material events, financial results, and governance changes related to its operations and securities.
Recent Form 8-K filings illustrate how Revvity communicates with the market. The company files 8-Ks to furnish earnings press releases for its quarterly results, to announce preliminary expectations for financial performance, and to provide presentation materials for major investor conferences such as the J.P. Morgan Healthcare Conference. Other 8-Ks disclose board and executive appointments and confirm details about its registered securities, including common stock and notes listed on the New York Stock Exchange.
Through its filings and accompanying earnings materials, Revvity explains the use of non-GAAP financial measures such as adjusted earnings per share, adjusted operating income, and organic revenue growth. The company describes how management uses these measures to evaluate operating performance, benchmark results, and inform compensation decisions, while also outlining the limitations of non-GAAP metrics and providing reconciliations to GAAP figures.
On this page, Stock Titan surfaces Revvity’s SEC filings with real-time updates from EDGAR and AI-powered summaries that clarify the purpose and implications of each document. Users can quickly understand the key points of quarterly results, changes in guidance, capital allocation actions, and governance updates without reading every line of the original filings. Access to these filings, including Form 8-Ks and related exhibits, helps investors, analysts, and researchers track how Revvity reports its financial condition, segment performance, and significant corporate events over time.
T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G/A reporting a significant passive ownership stake in Revvity Inc. (common stock). The firm reports beneficial ownership of 22,447,103 shares, representing 19.8% of the class, with sole voting and dispositive power over these shares.
The filing notes that clients and funds advised by T. Rowe Price ultimately receive dividends and sale proceeds, and any delegated discretionary authority can be revoked. The T. Rowe Price Capital Appreciation Fund holds 14,366,588 shares, or 12.7% of the class. T. Rowe Price states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control, and expressly denies beneficial ownership beyond its advisory role.
Revvity, Inc. reported equity compensation and tax withholding transactions for senior vice president, global operations, Tajinder S. Vohra. On February 4, 2026, Vohra received 4,448 time-based restricted stock units that vest in three equal annual installments starting on the first anniversary of the grant, bringing his directly owned common stock to 14,531 shares.
On the same date, 359 shares of common stock were surrendered at
Revvity, Inc. insider Prahlad R. Singh, President, Chief Executive Officer and Director, reported multiple equity transactions dated February 4–5, 2026. On February 4, 3,421 shares of common stock were surrendered at
Singh also received a nonqualified stock option for 76,647 shares at an exercise price of
After these transactions, Singh reported 120,213 shares of Revvity common stock held directly. An additional 46,583 shares are held indirectly by the Singh Family Trust of 2021 for the sole benefit of his children, with beneficial ownership disclaimed except for any pecuniary interest.
Revvity, Inc. Senior Vice President, Administration, General Counsel and Secretary Joel S. Goldberg reported multiple equity transactions. On February 4, 2026, 869 common shares were withheld at
On February 5, 2026, a previously granted stock option for 12,717 shares was exercised at
REVVITY, INC. executive Maxwell Krakowiak, Senior Vice President and Chief Financial Officer, reported multiple equity transactions dated February 4, 2026. He surrendered 708 shares of common stock at
He also acquired 7,262 time-based restricted stock units at no cost, bringing his directly held common stock to 18,771 shares. In addition, he received a non-qualified stock option for 20,771 shares at an exercise price of
Revvity, Inc. Senior Vice President and Chief Commercial Officer Miriame Victor reported equity compensation activity on February 4, 2026. She received 5,401 time-based restricted stock units at no cost and was granted a nonqualified stock option for 15,449 shares at an exercise price of $103.395 per share.
To cover tax withholding on previously granted restricted stock units that vested the same day, 536 common shares were surrendered at a price of $101.13 per share. After these transactions, she directly holds 19,153 shares of common stock and 15,449 options, all vesting in three equal annual installments beginning on the first anniversary of the grant date.
Revvity, Inc. insider plans to sell common stock under Rule 144. A holder filed to sell 25,525 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $2,557,886.18, when 113,375,621 shares were outstanding. The shares were acquired by exercising a stock option originally granted on 02/05/2019, with the option exercised and paid in cash on 02/05/2026.
RVTY has a planned insider sale of common stock under Rule 144. The notice covers 12,717 common shares to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,274,382.22.
The shares relate to a stock option granted on 02/05/2019 and acquired on 02/05/2026, with the purchase price paid in cash. The filing notes that 113,375,621 shares of the issuer’s common stock were outstanding, providing context for the size of the planned sale.
Revvity, Inc. executive Tajinder S. Vohra exercised and sold stock options in a planned transaction. On 02/02/2026, Vohra exercised a nonqualified stock option for 5,756 shares of common stock at
The option, which vested in three equal annual installments beginning on February 5, 2020, was fully exercised, leaving 0 derivative securities. After the sale, Vohra directly owned 10,442 shares of Revvity common stock. The sale was made under a pre-established Rule 10b5-1 trading plan adopted on February 20, 2025. Vohra serves as Senior Vice President, Global Operations.
A holder of RVTY common stock has filed a Rule 144 notice to sell 5,756 shares through Fidelity Brokerage Services LLC on the NYSE around 02/02/2026, with an aggregate market value of 601502.00.
The issuer had 113,375,621 shares of common stock outstanding. The shares to be sold were acquired as a result of stock options granted on 02/05/2019 and exercised for cash on 02/02/2026.